Europe
Synthetic biology company, Camena Bioscience, announces a significant breakthrough in DNA synthesis accuracy with the development of an innovative technology called gSynth™.
Partnership in iABC project will accelerate Alaxia’s development of promising antimicrobial therapy for cystic fibrosis
The members of the Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Tuesday 28 April 2020 at the company’s headoffice in Botkyrka, have now been appoined.
Pharma and life sciences companies strengthen their executive and leadership teams with this week’s appointments.
This morning’s approval from the U.S. Food and Drug Administration marks the 11th therapeutic indication for Botox, a product tent pole for Ireland-based Allergan.
GlaxoSmithKline’s PARP inhibitor Zejula has been approved for wider use in some cancers.
Adocia, a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of proteins and peptides, announced third quarter revenue and net cash position as of September 30, 2019.
Life sciences companies from across Europe and Asia provide updates on their business and pipelines.
The agreement revolves around the development and commercialization of Pliant’s preclinical candidate, PLN-1474, and up to three more integrin targets for liver fibrosis associated with nonalcoholic steatohepatitis.
MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM ‘19, last week in Barcelona.
PRESS RELEASES